Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
Sign in
  • Home
  • Biotech News
  • Conferences
    • Gold Conferences
    • Biotech Conferences
    • Technology Conferences
  • CoronaVirus
    • Precision Vaccinations
  • Internet News
  • Research
  • Reverse Splits
    • Reverse Split News
    • Reverse Split Watch List
    • Reverse Stock Split List
    • Upcoming Reverse Stock Split List
  • More Finance Channels
    • Beverage Stocks
    • Blockchain Stocks
    • Gold Stocks
    • Marijuana Stocks
    • Psychedelic Stocks
    • Stand Down – Wall Street Bears
    • Tiki Hut Fund
Sign in
Welcome!Log into your account
Forgot your password?
Privacy Policy
Password recovery
Recover your password
Search
Tuesday, May 26, 2026
  • Sign in / Join
  • Contact Us
  • Featured News
  • Free Weekly Newsletter
Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.

Internet | Biotech Stock Review

  • Home
  • Biotech News
  • Conferences
    • Gold Conferences
    • Biotech Conferences
    • Technology Conferences
  • CoronaVirus
    • Precision Vaccinations
  • Internet News
  • Research
  • Reverse Splits
    • Reverse Split News
    • Reverse Split Watch List
    • Reverse Stock Split List
    • Upcoming Reverse Stock Split List
  • More Finance Channels
    • Beverage Stocks
    • Blockchain Stocks
    • Gold Stocks
    • Marijuana Stocks
    • Psychedelic Stocks
    • Stand Down – Wall Street Bears
    • Tiki Hut Fund
Hapbee, Biotech Stock Review
All News

Hapbee Technologies (HAPB): Updates and News Archive.

Editor / Curator - October 31, 2020
Hapbee, Biotech Stock Review
Telehealth

Hapbee (HAPB) Soars 136% the First Day of Trading!

Editor / Curator - October 31, 2020
Hapbee, Biotech Stock Review
Accelerator

Telehealth App Hapbee (HAPB) Goes Public and More.

Editor / Curator - October 30, 2020
Hapbee,
All News

Hapbee (HAPB) to Commence Trading on the TSX Venture Exchange.

Editor / Curator - October 28, 2020
Dalarada Health, Biotech Stock Review
All News

Dalrada Cervical Cancer Testing Kit Study.

Editor / Curator - October 28, 2020
biotech stock review
All News

Dalrada’s ‘VIA’ Test Screening Kit Goes Head to Head with ‘Pap’...

Editor / Curator - October 27, 2020
Issam Radd
2020 Watch List

Citius Pharma (CTXR) Shareholder Letter | Year Ahead Roadmap.

Editor / Curator - October 27, 2020
Biosig
Biotech News

Adding BioSig (BSMG) $2.95 to Watch List.

Editor / Curator - October 26, 2020
Hepion, Biotech Stock Review
CoronaVirus

Hepion Pharma (HEPA): News Archive

Editor / Curator - October 24, 2020
roland rick perry
Biotech News

Can This Diabetes Drug Make you Smarter?

Editor / Curator - October 23, 2020
1...727374...108Page 73 of 108

Reverse Stock Split, Watch List

Plan Your Day Wisely

May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Apr    

AI Powered Biotech Research Tool

Reverse Stock Split News

Institutional Gold Research

Latest article

GeoVax (GOVX) Monkeypox (MPOX) PowerPoint.

Uncategorized Editor / Curator - May 26, 2026
In a recent press release, GeoVax shared progress on their MPOX Vaccine. The planned Phase 3 immuno-bridging arm of the clinical trial is expected to...

Rick Rule Symposium – Conference Cheat Sheet

2026 Watch List Editor / Curator - May 24, 2026
Natural Resource Investing Symposium - Presenter Guide We've attended hundreds and hundreds of Investment Conferences (Barclay, JP Morgan, LD Micro, Piper Sandler, Roth, VRIC) since...

GeoVax (GOVX) Surges 256%, With 207 Million Shares Trading!

2026 Biotech 12 Pack Editor / Curator - May 21, 2026
What an Entertaining Week! ..and it's only Thursday. LIVE QUOTE (MAY 18TH) (MAY 21ST) So Where Does That Leave us Today? Yes, it was a pleasant surprise to see GeoVax...
Revelers.IO Finance Channel
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
  • Model Portfolio
  • Disclaimer
  • Contact us
  • Write For Us
© Managed by Revelers.IO Media Group Inc.